Breast Cancer Trial, Recruiting NCT07041762 Sponsor: Cairo University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07041762
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women diagnosed with breast cancer who are scheduled to have a type of surgery called a Modified Radical Mastectomy (a procedure to remove the breast and nearby lymph nodes)
  • People with a moderate level of overall health, classified by doctors as ASA physical status II or III (meaning they have mild to moderate health conditions but are not critically ill) (confirm with trial site)
  • People aged between 18 and 65 years old
  • People with a Body Mass Index (BMI) — a measure of body weight relative to height — between 20 and 35

Who may not be able to join:

  • People who do not wish to participate
  • People in very poor overall health, classified as ASA physical status IV (meaning they have a severe, life-threatening condition) (confirm with trial site)
  • People younger than 18 or older than 65 years of age
  • People with a BMI below 20 or above 35
  • People with a known allergy or medical reason to avoid local anaesthetics or opioid pain medicines
  • People with a history of psychological disorders or long-term chronic pain
  • People with medical conditions that make certain nerve-blocking techniques unsafe, such as blood clotting problems, an infection near the injection site, or nerve damage
  • People with serious disease affecting the lungs, heart, liver, or kidneys

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sayed Mahmoud M Abed, MD, National Cancer Institute - Cairo University

Phone: +20 122 680 6532

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Postoperative Pain Scores; Total Opioid Consumption

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov